Wolverine Asset Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Wolverine Asset Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.6K	Buy	+2,127	New	+$44.2K	﹤0.01%	1276
2025 Q3	–	Sell	-2,091	Closed	-$16.7K	–	1756
2025 Q2	$16.7K	Sell	2,091 -6,793	-76%	-$56.5K	﹤0.01%	1332
2025 Q1	$79.9K	Sell	8,884 -3,809	-30%	-$41.6K	﹤0.01%	1120
2024 Q4	$181K	Buy	+12,693	New	+$137K	﹤0.01%	1043
2023 Q3	–	Sell	-12,448	Closed	-$26K	–	1935
2023 Q2	$26K	Buy	+12,448	New	+$26.8K	﹤0.01%	1247
2023 Q1	–	Sell	-1,462	Closed	-$1.27K	–	2013
2022 Q4	$1.27K	Buy	+1,462	New	+$1.2K	﹤0.01%	1922

Other funds holding NAMSW

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wolverine Asset Management's NAMSW Position: Q1 2026 in Review

Wolverine Asset Management opened a new position in NewAmsterdam Pharma Warrant (NAMSW) in Q1 2026: 2,127 shares worth $42.6K. The stake represents ﹤0.01% of the portfolio and ranks #1276 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in NAMSW as recently as Q2 2025.

Wolverine Asset Management first reported a position in NAMSW in Q4 2022 and has held it in 6 quarters since. The position peaked at $181K in Q4 2024. 9 funds tracked by Wall St. Rank hold NAMSW as of Q1 2026.

Wolverine Asset Management held 2,127 shares of NewAmsterdam Pharma Warrant worth $42.6K as of Q1 2026.
NewAmsterdam Pharma Warrant was a new Wolverine Asset Management position in Q1 2026.
NewAmsterdam Pharma Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1276 holding.
Wolverine Asset Management first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and has held it in 6 quarters since.
Wolverine Asset Management's NewAmsterdam Pharma Warrant position peaked at $181K in Q4 2024.
9 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.